CHRNA4 and Pain: Previous studies have shown that GeXIVA[1,2] could selectively acts on α9α10 nAChR and has good analgesic activity in rats model of chronic constriction injury (CCI) [18] and chemotherapy-induced neuropathic pain (CINP) [27] administrated by IM injection.